vs
ANAVEX LIFE SCIENCES CORP.（AVXL）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是ANAVEX LIFE SCIENCES CORP.的1.7倍（$1.9M vs $1.1M），ANAVEX LIFE SCIENCES CORP.净利率更高（-526.5% vs -974.7%，领先448.2%），Rigetti Computing, Inc.同比增速更快（-17.9% vs -22.6%），过去两年ANAVEX LIFE SCIENCES CORP.的营收复合增速更高（-21.6% vs -21.8%）
Anavex Life Sciences Corp是一家临床阶段生物制药企业，专注于开发针对阿尔茨海默病、雷特综合征、帕金森病等神经退行性及神经发育障碍的小分子创新疗法，主要业务覆盖北美及欧洲市场，面向存在未满足医疗需求的患者群体。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
AVXL vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.7倍
$1.1M
营收增速更快
RGTI
高出4.7%
-22.6%
净利率更高
AVXL
高出448.2%
-974.7%
两年增速更快
AVXL
近两年复合增速
-21.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $1.9M |
| 净利润 | $-5.7M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -628.5% | -1209.7% |
| 净利率 | -526.5% | -974.7% |
| 营收同比 | -22.6% | -17.9% |
| 净利润同比 | 53.1% | 88.1% |
| 每股收益（稀释后） | $-0.06 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVXLRGTI
| Q4 25 | $1.1M | $1.9M | ||
| Q3 25 | $999.0K | $1.9M | ||
| Q2 25 | $1.1M | $1.8M | ||
| Q1 25 | $1.2M | $1.5M | ||
| Q4 24 | $1.4M | $2.3M | ||
| Q3 24 | $1.8M | $2.4M | ||
| Q2 24 | $1.8M | $3.1M | ||
| Q1 24 | $1.8M | $3.1M |
净利润AVXLRGTI
| Q4 25 | $-5.7M | $-18.2M | ||
| Q3 25 | $-9.8M | $-201.0M | ||
| Q2 25 | $-13.2M | $-39.7M | ||
| Q1 25 | $-11.2M | $42.6M | ||
| Q4 24 | $-12.1M | $-153.0M | ||
| Q3 24 | $-11.6M | $-14.8M | ||
| Q2 24 | $-12.2M | $-12.4M | ||
| Q1 24 | $-10.5M | $-20.8M |
毛利率AVXLRGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率AVXLRGTI
| Q4 25 | -628.5% | -1209.7% | ||
| Q3 25 | -1085.5% | -1055.4% | ||
| Q2 25 | -1345.0% | -1103.9% | ||
| Q1 25 | -1034.1% | -1469.6% | ||
| Q4 24 | -975.0% | -813.3% | ||
| Q3 24 | -810.9% | -729.4% | ||
| Q2 24 | -813.1% | -521.2% | ||
| Q1 24 | -718.9% | -543.4% |
净利率AVXLRGTI
| Q4 25 | -526.5% | -974.7% | ||
| Q3 25 | -983.7% | -10321.9% | ||
| Q2 25 | -1231.9% | -2201.8% | ||
| Q1 25 | -925.3% | 2895.3% | ||
| Q4 24 | -868.8% | -6726.5% | ||
| Q3 24 | -660.2% | -623.8% | ||
| Q2 24 | -680.1% | -402.5% | ||
| Q1 24 | -600.6% | -680.6% |
每股收益（稀释后）AVXLRGTI
| Q4 25 | $-0.06 | $-0.08 | ||
| Q3 25 | $-0.11 | $-0.62 | ||
| Q2 25 | $-0.16 | $-0.13 | ||
| Q1 25 | $-0.13 | $0.13 | ||
| Q4 24 | $-0.14 | $-0.80 | ||
| Q3 24 | $-0.14 | $-0.08 | ||
| Q2 24 | $-0.14 | $-0.07 | ||
| Q1 24 | $-0.13 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $131.7M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $126.6M | $546.2M |
| 总资产 | $133.0M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVXLRGTI
| Q4 25 | $131.7M | $44.9M | ||
| Q3 25 | $102.6M | $26.1M | ||
| Q2 25 | $101.2M | $57.2M | ||
| Q1 25 | $115.8M | $37.2M | ||
| Q4 24 | $120.8M | $67.7M | ||
| Q3 24 | $132.2M | $20.3M | ||
| Q2 24 | $138.8M | $20.7M | ||
| Q1 24 | $139.4M | $35.1M |
股东权益AVXLRGTI
| Q4 25 | $126.6M | $546.2M | ||
| Q3 25 | $94.9M | $371.8M | ||
| Q2 25 | $91.0M | $553.3M | ||
| Q1 25 | $99.8M | $207.1M | ||
| Q4 24 | $110.9M | $126.6M | ||
| Q3 24 | $120.3M | $122.8M | ||
| Q2 24 | $129.8M | $122.2M | ||
| Q1 24 | $135.0M | $115.6M |
总资产AVXLRGTI
| Q4 25 | $133.0M | $666.6M | ||
| Q3 25 | $103.8M | $630.3M | ||
| Q2 25 | $102.4M | $636.7M | ||
| Q1 25 | $117.1M | $269.1M | ||
| Q4 24 | $124.0M | $284.8M | ||
| Q3 24 | $135.6M | $157.3M | ||
| Q2 24 | $141.5M | $162.4M | ||
| Q1 24 | $144.5M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.2M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.5M |
| 自由现金流率自由现金流/营收 | — | -1042.5% |
| 资本支出强度资本支出/营收 | — | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-77.2M |
8季度趋势，按日历期对齐
经营现金流AVXLRGTI
| Q4 25 | $-7.2M | $-14.9M | ||
| Q3 25 | $-8.6M | $-13.8M | ||
| Q2 25 | $-12.5M | $-16.2M | ||
| Q1 25 | $-5.9M | $-13.7M | ||
| Q4 24 | $-12.1M | $-8.5M | ||
| Q3 24 | $-6.7M | $-15.4M | ||
| Q2 24 | $-5.2M | $-13.5M | ||
| Q1 24 | $-11.7M | $-13.1M |
自由现金流AVXLRGTI
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | — | $-18.6M |
自由现金流率AVXLRGTI
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | — | -610.5% |
资本支出强度AVXLRGTI
| Q4 25 | — | 244.8% | ||
| Q3 25 | — | 302.5% | ||
| Q2 25 | — | 314.7% | ||
| Q1 25 | — | 173.0% | ||
| Q4 24 | — | 56.4% | ||
| Q3 24 | — | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | — | 180.0% |
现金转化率AVXLRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVXL
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
